Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-936,607
Closed -$6.86M 174
2024
Q4
$6.86M Sell
936,607
-585,827
-38% -$5.39M 0.03% 91
2024
Q3
$17.5M Sell
1,522,434
-339,603
-18% -$4.07M 0.08% 67
2024
Q2
$24.6M Sell
1,862,037
-255,573
-12% -$3.65M 0.1% 56
2024
Q1
$30.3M Sell
2,117,610
-251,112
-11% -$3.24M 0.12% 57
2023
Q4
$25.3M Buy
+2,368,722
New +$24.1M 0.11% 57

Other funds holding ABVX

Blackstone Inc's ABVX Position: Q1 2025 in Review

Blackstone Inc sold out of Abivax (ABVX) in Q1 2025, closing a stake of 936,607 shares — an estimated $6.86M sold.

Blackstone Inc first reported a position in ABVX in Q4 2023 and held it in 5 quarters. The position peaked at $30.3M in Q1 2024. 46 funds tracked by Wall St. Rank hold ABVX as of Q1 2025.

  • Blackstone Inc reported no remaining Abivax position as of Q1 2025 after selling out during the quarter.
  • Blackstone Inc sold 936,607 Abivax shares in Q1 2025, an estimated $6.86M.
  • Blackstone Inc first reported a position in Abivax in Q4 2023 and held it in 5 quarters.
  • Blackstone Inc's Abivax position peaked at $30.3M in Q1 2024.
  • 46 funds tracked by Wall St. Rank held Abivax as of Q1 2025.

Based on Blackstone Inc's 13F filing for Q1 2025, filed 15 May 2025.